MedTrace Logo

Evaluation of Vision After Vivity IOL Implantation With a Target of Slight Myopia in the Non-dominant Eye

NCT04482439 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2022-03-03

Study results available
· View outcomes & findings →

Summary

The objective is to assess binocular distance-corrected near (40 cm) visual acuity of patients after uneventful cataract surgery with bilateral implantation of the AcrySof® Vivity Intraocular lens (IOL) when the non-dominant eye is targeted for slight myopia.

Conditions

  • Cataract

Interventions

DEVICE

Vivity Extended Depth of Focus intraocular lens (IOL)

Bilateral implantation of the Vivity lens after cataract surgery, with slight myopia planned in the non-dominant eye.

Sponsors & Collaborators

  • Newsom Eye & Laser Center

    lead OTHER

Principal Investigators

  • Thomas Newsom, MD · Newsom Eye & Laser Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-17
Primary Completion
2021-06-10
Completion
2021-06-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04482439 on ClinicalTrials.gov